Enzymax DuoBiotics for Irritable Bowel Syndrome | MicrobiomeTrials← Back to trialsNCT07716852
Enzymax DuoBiotics for Irritable Bowel Syndrome
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-09-30Est. Completion: 2027-06-23
Enrollment target: 120 participants Other microbiome trials you might be interested in
Functional Somatic DisorderSomatic Symptom Disorder
Functional somatic syndromes (e.g. irritable bowel syndrome, fibromyalgia) and medically unexplained symptoms (e.g. chro…
Stockholm, SwedenCompleted Jun 1, 2024
Irritable Bowel Syndrome
Irritable Bowel Syndrome (IBS), characterized by the Rome IV criteria, is a functional bowel disorder combining abdomina…
Lyon, FranceEst. completion Oct 10, 2028
Completed
Functional Somatic DisorderSomatic Symptom DisorderFunctional Somatic Syndromes
Functional somatic syndromes (e.g. irritable bowel syndrome, fibromyalgia) and medically unexplained symptoms (e.g. chro…
Stockholm, SwedenCompleted Jan 1, 2025